Advertisement

Topics

Companies Related to "Phase I Clinical Study in the Treatment of HER2-positive Recurrent or Metastatic Breast Cancer.∨derfield=score∨derval=desc⊂mit=Search" [Most Relevant Company Matches] RSS

10:22 EDT 16th July 2019 | BioPortfolio

Here are the most relevant search results for "Phase I Clinical Study in the Treatment of HER2-positive Recurrent or Metastatic Breast Cancer.∨derfield=score∨derval=desc⊂mit=Search" found in our extensive corporate database of over 50,000 company records.

Showing "Phase Clinical Study Treatment HER2 positive Recurrent Metastatic" Companies 1–25 of 8,400+

Tuesday 16th July 2019

NaphCare, Inc.

NaphCare, Inc., partners with city, county, state and federal correctional facilities nationwide to provide proactive, patient-focused healthcare to more than 125,000 patients. The company’s innovative approach to correctional healthcare includes designing and implementing evidence-based clinical programs to address the specific challenges of the corrections environment. NaphCare provides co...


Generational Equity

Generational Equity provides mergers, acquisitions, strategic growth advisory services, and information for privately held and family-owned businesses to exit their business successfully. A unique, four-phase approach that includes education, financial analysis and reporting, sales documentation and deal-making ability combine to offer business owners an unparalleled level of commitment and exper...

Ra Pharmaceuticals and Camurus AB

Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.


Monday 15th July 2019

Imugene Ltd

Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and oth...

SI-BONE, Inc.

SI-BONE, Inc. (Cupertino, California) is a leading spinal medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to sacroiliac (SI) joint pathology. The company has developed, and is manufacturing and marketing, less invasive approaches using implants for the treatment of SI Joint pathology. SI-BONE has an exper...

Friday 12th July 2019

Alzamend Neuro, Inc.

Alzamend Neuro™, Inc. is a Delaware corporation with its corporate headquarters in the State of Florida. The mission of Alzamend Neuro™ is to support the full product development life cycle of treatment and cures for Alzheimer’s driven by the belief that strong support of research is the foundation for true innovation. The Company is providing current hope through the commercializa...

Thursday 11th July 2019

Rasmussen College

To help meet employer demands, Rasmussen College’s hands-on PTA program is designed to help students earn their degree in an immersive setting, develop their confidence and arm them with the skills employers seek. Students learn to improve a patient’s mobility and decrease pain, as well as gain the ability to comfortably and confidently interact with professionals and patients in a vari...

Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmu...

Wednesday 10th July 2019

Osivax

Osivax’s mission is to revolutionize influenza prevention with a universal flu vaccine for both current and future Influenza A and B infections by leveraging its unique oligoDOM® technology platform. The most advanced candidate, a broad-spectrum A-strain flu vaccine is in Phase 1 clinical development. Osivax is focused on providing proof-of-concept in Influenza A firstly to save lives and...

Tuesday 9th July 2019

The MEDICREA Group

Through the lens of predictive medicine, Medicrea leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room.

Psychiatric Medical Care, LLC

Founded in 2003 and based in Nashville, TN, Psychiatric Medical Care (PMC) is a leading behavioral healthcare management company focused on addressing the needs of rural and underserved communities. Operating in more than 20 states, the company manages both inpatient psychiatry units and intensive outpatient psychiatry programs within hospitals. PMC also provides telepsychiatry services across a ...

Dermatology Times®

A multimedia platform for dermatologists, Dermatology Times® provides regulatory and clinical updates, as well as discussion on cost-effective practice management solutions. Dermatology Times® helps dermatology professionals grow their knowledge and advance their practice to improve patient care by providing them with the latest news and trends in dermatologic procedures, therapy, technolog...

Annexon Biosciences

Annexon’s pipeline of novel therapies includes two clinical-stage product candidates, ANX005, a monoclonal antibody, and ANX007, a fragmented monoclonal antibody, as well as other compounds in preclinical development. ANX005 is currently in a Phase 1/2 study in patients with Guillain-Barre Syndrome (GBS). Annexon also plans to evaluate ANX005 in complement-mediated neurodegenerative disorder...

Allscripts Healthcare Solutions, Inc.

Allscripts (Nasdaq: MDRX) is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The company's unique solutions inform, connect and transform healthcare, delivering improved care at lower cost. More than 40,000 physicians and thousands of other healthcare professionals in clinics, hospitals and extended care facilities ...

Monday 8th July 2019

AHMC Healthcare Inc.

AHMC Healthcare Inc., operating six acute care hospitals in Southern California having 1,102 total beds and over 6,000 employees, has established itself as a healthcare provider offering a wide range of services from primary to tertiary care. Attracting the most qualified and dedicated staff, AHMC Healthcare Inc. and its affiliated hospitals are recognized...

CTD Holdings, Inc.

CTD Holdings, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C, a rare and fatal genetic disease, on a compassionate use basis as well as in three ongoing formal clinical t...

Friday 5th July 2019

COBO Technologies

COBO Technologies is a fast-growing CRO specialised in services and products for quality control of genome editing applications in research and clinical fields. The company supports customers globally with detailed DNA mutation analysis and complexed protein expression profiling of cells, plants or animals modified with genome editing tools such as Meganucleases CRISPR-Cas9, ZFNs and TALENs.

Wednesday 3rd July 2019

Onco360® Oncology Pharmacy

Onco360 is the largest independent Oncology Pharmacy and clinical support services company in the country. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It dispenses nationally through its network of U...

Bioscience Association Manitoba

Read the study here: https://www.biomb.ca/news/reports/561/2019-bam-industry-profile-study

Monday 1st July 2019

Independence Plus, Inc.

For more than 32 years, Independence Plus, Inc. (IPI) has been a leading provider of complex care at-home with an integrated approach conducted by a multidisciplinary team. We specialize in treating adult and pediatric patients with complex medical and respiratory needs, offering the highest quality one-on-one care with 24/7 on-call clinical management support, skilled intermittent visits and hig...

Change Healthcare Inc.

Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system. We are a key catalyst of a value-based healthcare system, accelerating the journey toward improved lives and healthier communities.

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of small molecule drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across m...

Friday 28th June 2019

Promedica International

Promedica International is a provider of CRO services to themedical device, biotech and pharmaceutical industries. Specializing in projectsinvolving innovative technology, our experienced staff and ISO-certified processesare the primary factors enabling us to consistently provide services highly regarded by our clients and their related study teams

Newron Pharmaceutical S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the US, Australia, Canada, Br...

Thursday 27th June 2019

Elite Skin & Lash

Serving Colleyville, Southlake, Westlake, Fort Worth, Keller, and the surrounding areas, Elite Skin and Lash offers an array of treatments ranging from facials, microdermabrasion, chemical peels, eyelash extensions, massage, laser, and skin tightening services. The clinical result-driven treatments including age management, anti-aging, pigmentation, wrinkle treatment, and acne treatment are alway...


More From BioPortfolio on "Phase I Clinical Study in the Treatment of HER2-positive Recurrent or Metastatic Breast Cancer.∨derfield=score∨derval=desc⊂mit=Search"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks